KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,473 | -23.0% | 3,775 | +27.3% | 0.00% | -33.3% |
| Q2 2023 | $68,165 | -22.4% | 2,965 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $87,853 | -16.7% | 2,965 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $105,495 | +64.8% | 2,965 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $64,000 | +25.5% | 2,965 | +12.6% | 0.00% | +50.0% |
| Q2 2022 | $51,000 | -54.1% | 2,634 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $111,000 | -33.5% | 2,634 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $167,000 | +7.7% | 2,634 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $155,000 | +40.9% | 2,634 | +16.2% | 0.01% | +50.0% |
| Q2 2021 | $110,000 | +233.3% | 2,267 | +168.3% | 0.00% | +300.0% |
| Q1 2021 | $33,000 | -36.5% | 845 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $52,000 | – | 845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |